ArticleCurrent oncology (Toronto, Ont.)2025

Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma.

Annette M Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.